Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?
Authors
Keywords
-
Journal
ANNALS OF MEDICINE
Volume 48, Issue 8, Pages 614-624
Publisher
Informa UK Limited
Online
2016-06-20
DOI
10.1080/07853890.2016.1197416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A neglected modulator of insulin-degrading enzyme activity and conformation: The pH
- (2015) Giuseppe Grasso et al. BIOPHYSICAL CHEMISTRY
- Modulation of insulin degrading enzyme activity and liver cell proliferation
- (2015) Olga Pivovarova et al. CELL CYCLE
- Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearancein Vivo
- (2015) Timothy B. Durham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impaired insulin action in the human brain: causes and metabolic consequences
- (2015) Martin Heni et al. Nature Reviews Endocrinology
- Accumulation of BRI2-BRICHOS ectodomain correlates with a decreased clearance of Aβ by insulin degrading enzyme (IDE) in Alzheimer’s disease
- (2015) M. Del Campo et al. NEUROSCIENCE LETTERS
- Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
- (2015) Xiaohua Li et al. Clinical Interventions in Aging
- Brain metabolic dysfunction at the core of Alzheimer's disease
- (2014) Suzanne M. de la Monte et al. BIOCHEMICAL PHARMACOLOGY
- Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis
- (2014) Julie Charton et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis
- (2014) Huawei Cheng et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
- (2014) Juan Pablo Maianti et al. NATURE
- The role of glucagon on type 2 diabetes at a glance
- (2014) Amélio F Godoy-Matos Diabetology & Metabolic Syndrome
- Nonsteroidal Selective Androgen Receptor Modulators and Selective Estrogen Receptor β Agonists Moderate Cognitive Deficits and Amyloid-β Levels in a Mouse Model of Alzheimer’s Disease
- (2013) Sonia George et al. ACS Chemical Neuroscience
- Sevoflurane alters the expression of receptors and enzymes involved in Aβ clearance in rats
- (2013) Y. LIU et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- The Type 2 Diabetes-Associated Gene Ide Is Required for Insulin Secretion and Suppression of -Synuclein Levels in -Cells
- (2013) P. Steneberg et al. DIABETES
- Hepatic Insulin Clearance Is Closely Related to Metabolic Syndrome Components
- (2013) O. Pivovarova et al. DIABETES CARE
- Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice
- (2013) Marta Dobarro et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity
- (2013) Samer O. Abdul-Hay et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice
- (2013) Pengwen Wang et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques
- (2013) Min-Kyoo Shin et al. NEUROBIOLOGY OF AGING
- Relationship between amyloid-beta and the ubiquitin–proteasome system in Alzheimer’s disease
- (2013) Liang Hong et al. NEUROLOGICAL RESEARCH
- Meta-analysis of the insulin degrading enzyme polymorphisms and susceptibility to Alzheimer's disease
- (2013) Yunyun Zhang et al. NEUROSCIENCE LETTERS
- Structure Based Discovery of Small Molecules to Regulate the Activity of Human Insulin Degrading Enzyme
- (2012) Bilal Çakir et al. PLoS One
- Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis
- (2011) Domenico Bosco et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance
- (2011) Samer O. Abdul-Hay et al. PLoS One
- Identification of the Allosteric Regulatory Site of Insulysin
- (2011) Nicholas Noinaj et al. PLoS One
- Insulin metabolism in human adipocytes from subcutaneous and visceral depots
- (2010) Janet Fawcett et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Changes with Age in the Activities of β-Secretase and the Aβ-Degrading Enzymes Neprilysin, Insulin-Degrading Enzyme and Angiotensin-Converting Enzyme
- (2010) J. Scott Miners et al. BRAIN PATHOLOGY
- Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
- (2010) Kawser Akter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Norepinephrine Promotes Microglia to Uptake and Degrade Amyloid Peptide through Upregulation of Mouse Formyl Peptide Receptor 2 and Induction of Insulin-Degrading Enzyme
- (2010) Y. Kong et al. JOURNAL OF NEUROSCIENCE
- How does diabetes accelerate Alzheimer disease pathology?
- (2010) Catrina Sims-Robinson et al. Nature Reviews Neurology
- Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease
- (2010) Minerva M. Carrasquillo et al. PLoS One
- Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
- (2010) Malcolm A. Leissring et al. PLoS One
- Non-viral causes of hepatocellular carcinoma
- (2010) Wojciech Blonski WORLD JOURNAL OF GASTROENTEROLOGY
- A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimers Disease
- (2009) Sergey Kalinin et al. Current Alzheimer Research
- Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells
- (2009) O. Pivovarova et al. DIABETOLOGIA
- Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes
- (2009) Natalia Rudovich et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Neprilysin and Insulin-Degrading Enzyme Levels Are Increased in Alzheimer Disease in Relation to Disease Severity
- (2009) James Scott Miners et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The proteasomal system
- (2009) Tobias Jung et al. MOLECULAR ASPECTS OF MEDICINE
- Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening
- (2009) Christelle Cabrol et al. PLoS One
- Amyloid-Degrading Enzymes as Therapeutic Targets in Alzheimers Disease
- (2008) Natalia Nalivaeva et al. Current Alzheimer Research
- Stem cell antigen-1 localizes to lipid microdomains and associates with insulin degrading enzyme in skeletal myoblasts
- (2008) Conrad L. Epting et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Somatostatin: A Novel Substrate and a Modulator of Insulin-Degrading Enzyme Activity
- (2008) Chiara Ciaccio et al. JOURNAL OF MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More